Industry News
Pharmaceutical Industry News

Is It Safe to Use Eye Drops Every Day?
It depends on the formulation, experts say. Here’s what is (and isn’t) recommended for the long term.
It’s Time to Shop Medicare, and This Year, It’s Extra Important
Be sure to read your mail this fall — big changes to prescription drug plans and Medicare Advantage provider networks are coming, and could cost you more.
Trump Hasn’t Lowered Drug Prices for These Voters
President Trump has been promoting his efforts to reduce drug prices, but many Americans have not seen relief from rising costs for prescriptions and insurance premiums.
Choosing a Medicare Advantage Provider for 2027 May Be Easier, but Not Perfect
The government has made improvements to the Medicare Plan Finder, a key online tool, in time for open enrollment. It helps seniors compare policies to avoid costly surprises.
Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says
The attorneys general of New York and six other states joined the Federal Trade Commission in accusing the disgraced former pharmaceutical executive of repeatedly violating the ban.
Why Ketamine Immobilizes Some Users
Potent powders can produce a nearly catatonic state, particularly in those who have not tried the drug before.
Christa Pike Discharged From Hospital After Surviving Execution Attempt
Ms. Pike, 50 and convicted of the 1995 murder of a classmate, survived two doses of the drug pentobarbital late last month.
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’
New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful push for the Covid-19 vaccine.
Private Medicare Plans Are Raising Costs And Forcing Millions To Find New Insurance
As enrollment for Medicare Advantage begins this month, older Americans are confronting fewer options because insurers are discontinuing coverage in many areas.
I Consulted With Christa Pike’s Death Row Team. I Knew This Could Happen.
Lethal injection failures are not glitches; they are features of the process.
Scientists Untangle the Biology of an ‘Undruggable’ Cancer Gene
Found in 70 percent of cancers, the gene is seen as a grand orchestrator but has been surprisingly difficult to stop.
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
How Did Christa Pike Survive Two Lethal Injections of Pentobarbital?
A catheter carrying the drug may not have delivered the doses to Ms. Pike’s bloodstream, experts said. The drug itself may have been degraded.
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Why Do Clinical Trials for Cancer Drugs Take So Long?
Readers respond to a guest essay about the costs and delays in getting experimental treatments to patients.
An Idaho Cold Case Revisits the Unsolved Tylenol Killings in 1982
A man who killed himself that year in a church in Boise was known as the “Unknown Wanderer.” Investigators said he might have a connection to the famous case of tainted Tylenol.
GSK showed a “totally…
GSK showed a “totally unacceptable” lack of transparency in its interactions with the PMCPA, the U.K. self-regulatory body ruled.
Boehringer Ingelheim is bidding…
Boehringer Ingelheim is bidding adieu to its biologics contract manufacturing unit in China, inking a small-scale deal that gives local developer Raas Blood Products an established biologics production base for its lead antibody drug candidate.
The FDA has green-lighted…
The FDA has green-lighted Elevar’s FGFR2-selective inhibitor Lyrfigtu in bile duct cancer, making it the first novel cancer drug from a Korean company to secure FDA approval.


